Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John C. Martin Insider Profile
25 Followers
John C. Martin, Director at Gilead Sciences, holds 7.91K shares in Sarepta Therapeutics (Ticker: SRPT), holds 1.95M shares in Kronos Bio (Ticker: KRON), holds 2.89M shares in Gilead Sciences (Ticker: GILD).
Profitable Transactions
38 out of 62 Profitable Transactions
Average Return
+0.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John C. Martin holds in companies
Most Profitable Insider Trade
The most profitable trade made by John C. Martin
John C. Martin's Trading History
Gilead Sciences
Feb 08, 2019
Director
Uninformative Buy
―
$192.75M
Sarepta Therapeutics
Mar 05, 2021
Director
Uninformative Buy
―
$914.90K
Kronos Bio
Oct 16, 2020
Director
Informative Buy
3.31M
$1.97M
List of latest transactions for each holding click on a transaction to see John C. Martin's performance on stock
You May Also Like
John C. Martin insider profile FAQ
What is the percentage of profitable transactions made by John C. Martin?
The percentage of profitable transactions made by John C. Martin is 61%.
What is the average return per transaction made by John C. Martin?
The average return per transaction made by John C. Martin is 0.90%.
What stocks does John C. Martin hold?
John C. Martin holds: GILD, SRPT, KRON stocks.
What was John C. Martin’s latest transaction?
John C. Martin latest transaction was an Uninformative Buy of ―.
What was John C. Martin's most profitable transaction?
John C. Martin’s most profitable transaction was an Informative Sell of GILD stock on November 4, 2015. The return on the trade was 32.10%.
What is John C. Martin's role in Gilead Sciences?
John C. Martin's role in Gilead Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.